A new analysis from The Commonwealth Fund has found that the Cadillac tax will likely be more progressive than initially thought.
The so-called Cadillac tax is one of the few aspects of the Affordable Care Act that has united Democrats and Republicans. Both parties disliked it so much that they passed a bill that delays the tax until 2020. Now a new analysis from The Commonwealth Fund has found that the tax will likely be more progressive than initially thought.
The Cadillac tax is a 40% excise tax on employer plans exceeding $10,200 in premiums per year for individuals and $27,500 for families. The tax’s features are supposed to maximize revenue and minimize coverage disruptions. And The Commonwealth Fund has determined that the tax will only have a modest impact on total health spending.
It is important to note that premium contributions by employers and employees count against the threshold as do most contributions to health savings accounts (HSAs), flexible spending accounts (FSAs), Archer medical savings accounts, and health reimbursement accounts.
According to the report, when employers offered these accounts, employees were encouraged to buy more generous plans than they normally would have, which lead to higher spending through greater demand for medical care.
“High-income workers benefit the most because they have the highest tax rates and also have access to generous benefits, take up these benefits, and contribute to savings accounts,” the authors wrote.
Ownership and funding of HSAs and FSAs are typically more skewed toward high-income workers, and as such they will be most affected, initially, by the tax. Furthermore, account balances are highest among the highest earners, according to the research brief.
The result of the Cadillac tax will likely be that employers limit contributions to FSAs and HSAs, and that employers will offer plans with more restrictive networks.
“By taxing only the portion of plan costs that exceeds a threshold, the HCPT ensures that most employer-sponsored benefits will remain intact. However, the HCPT limits the tax benefits of health savings accounts, which may reduce the appeal of high-deductible plans,” the authors concluded.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More